Amedisys (AMED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Yet another shoe has dropped in the UnitedHealth Group/Amedisys saga. Last week, the Justice Department — along with the ...

In Lampo v. Amedisys Holding, LLC and Leisa Victoria Neasbitt, the South Carolina Supreme Court establishes important legal ...

Amedisys’ AMED continuously improving clinical quality for patients, demonstrated through high Quality of Patient Care and Patient Satisfaction star ratings, is poised to drive growth in the upcoming ...

Oppenheimer analyst Michael Wiederhorn is updating its Amedisys (AMED) model following the Q4 earnings release. Amedisys is currently in the ...

Amedisys (AMED) came out with quarterly earnings of $0.96 per share, missing the Zacks Consensus Estimate of $1.05 per share. This compares to earnings of $0.94 per share a year ago. These figures ...

(2) Adjusted EBITDA is defined as net (loss) income attributable to Amedisys, Inc. before net interest expense, provision for income taxes and depreciation and amortization, excluding certain ...

Amedisys shares have risen nearly 1% since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $91.57, a fall of roughly 3% in the last 12 months.

BATON ROUGE, La. (AP) — BATON ROUGE, La. (AP) — Amedisys Inc. (AMED) on Wednesday reported a fourth-quarter loss of $20.4 million, after reporting a profit in the same period a year earlier.